|
1
|
Hamid N, Albalawi N, Alanazi F, Alharbi F
and Aljabri M: Sickle cell disease in children in Saudi Arabia: A
systematic review. Int J Pharm Phytopharmacological Res. 11:97–102.
2021.
|
|
2
|
Oudi ME, Aouni Z, Mazigh C, Khochkar R,
Gazoueni E, Haouela H and Machghoul S: Homocysteine, and markers of
inflammation in acute coronary syndrome. Exp Clin Cardiol.
15:e25–e28. 2010.PubMed/NCBI
|
|
3
|
Carrero JJ, Andersson Franko M, Obergfell
A, Gabrielsen A and Jernberg T: hsCRP level and the risk of death
or recurrent cardiovascular events in patients with myocardial
infarction: A healthcare-based study. J Am Heart Assoc.
8(e012638)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ridker PM, Koenig W, Kastelein JJ, Mach F
and Lüscher TF: Has the time finally come to measure hsCRP
universally in primary and secondary cardiovascular prevention? Eur
Heart J. 39:4109–4111. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Okocha C, Manafa P, Ozomba J, Ulasi T,
Chukwuma G and Aneke J: C-reactive protein and disease outcome in
Nigerian sickle cell disease patients. Ann Med Health Sci Res.
4:701–705. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hatzipantelis ES, Pana ZD, Gombakis N,
Taparkou A, Tzimouli V, Kleta D, Zafeiriou DJ, Garipidou V,
Kanakoudi F and Athanassiou M: Endothelial activation and
inflammation biomarkers in children and adolescents with sickle
cell disease. Int J Hematol. 98:158–163. 2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zahran AM, Nafady A, Saad K, Hetta HF,
Abdallah AM, Abdel-Aziz SM, Embaby MM, Abo Elgheet AM, Darwish SF,
Abo-Elela MGM, et al: Effect of hydroxyurea treatment on the
inflammatory markers among children with sickle cell disease. Clin
Appl Thromb Hemost. 26(1076029619895111)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Schnog JB, Duits AJ, Muskiet FA, ten Cate
H, Rojer RA and Brandjes DP: Sickle cell disease; a general
overview. Neth J Med. 62:364–374. 2004.PubMed/NCBI
|
|
9
|
Krishnan S, Setty Y, Betal SG, Vijender V,
Rao K, Dampier C and Stuart M: Increased levels of the inflammatory
biomarker C-reactive protein at baseline are associated with
childhood sickle cell vasocclusive crises. Br J Haematol.
148:797–804. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Bargoma EM, Mitsuyoshi JK, Larkin SK,
Styles LA, Kuypers FA and Test ST: Serum creactive protein
parallels secretory phospholipase A2 in sickle cell disease
patients with vasoocclusive crisis or acute chest syndrome. Blood.
105:3384–3385. 2005.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mohammed FA, Mahdi N, Sater MA, Al-Ola K
and Almawi WY: The relation of C-reactive protein to vasoocclusive
crisis in children with sickle cell disease. Blood Cells Mol Dis.
45:293–296. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kerins DM, Koury MJ, Capdevila A, Rana S
and Wagner C: Plasma S-adenosylhomocysteine is a more sensitive
indicator of cardiovascular disease than plasma homocysteine. Am J
Clin Nutr. 74:723–729. 2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li T, Chen Y, Li J, Yang X, Zhang H, Qin
X, Hu Y and Mo Z: Serum homocysteine concentration is significantly
associated with inflammatory/immune factors. PLoS One.
10(e0138099)2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lowenthal EA, Mayo MS, Cornwell PE and
Thornley-Brown D: Homocysteine elevation in sickle cell disease. J
Am Coll Nutr. 19:608–612. 2000.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Dhar M, Bellevue R, Brar S and Carmel R:
Mild hyperhomocysteinemia in adult patients with sickle cell
disease: A common finding unrelated to folate and cobalamin status.
Am J Hematol. 76:114–120. 2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wu JT: Circulating homocysteine is an
inflammation marker and a risk factor of life-threatening
inflammatory diseases. J Biomed Lab Sci. 19:107–111. 2007.
|
|
17
|
Mohammed Al-Nuzaily and Faisal Ali: Sickle
cell anemia in relation to total homocysteine levels and the role
of anticoagulant proteins. Int J Pharm Clin. 6:192–195. 2014.
|
|
18
|
Ware RE, de Montalembert M, Tshilolo L and
Abboud MR: Sickle cell disease. Lancet. 390:311–323.
2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shet AS, Lizarralde-Iragorri MA and Naik
RP: The molecular basis for the pro-thrombotic state in sickle cell
disease. Haematologica. 105:2368–2379. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tentolouris A, Stafylidis C, Siafarikas C,
Dimopoulou MN, Makrodimitri S, Bousi S, Papalexis P, Damaskos C,
Trakas N, Sklapani P, et al: Favorable outcomes of patients with
sickle cell disease hospitalized due to COVID-19: A report of three
cases. Exp Ther Med. 23(338)2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Aygun B and Odame I: A global perspective
on sickle cell disease. Pediatr Blood Cancer. 59:386–390.
2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sundd P, Gladwin MT and Novelli EM:
Pathophysiology of sickle cell disease. Annu Rev Pathol.
14:263–292. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Abdel-Salam M, Ibrahim S, Pessar SA and
Al-Morsy E: The relationship between serum homocysteine and highly
sensitive C-reactive protein levels in children on regular
hemodialysis. Saudi J Kidney Dis Transpl. 28(483490)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Pandey S, Pandey HR, Mishra RM, Pandey S
and Saxena R: Increased homocysteine level in Indian sickle cell
anemia patients. Indian J Clin Biochem. 27:103–104. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Papandreou D, Mavromichalis I, Makedou A,
Rousso I and Arvanitidou M: Reference range of total serum
homocysteine level and dietary indexes in healthy Greek
schoolchildren aged 6-15 years. Br J Nutr. 96:719–724.
2006.PubMed/NCBI
|
|
26
|
van Beers EJ, Yang Y, Raghavachari N, Tian
X, Allen DT, Nichols JS, Mendelsohn L, Nekhai S, Gordeuk VR, Taylor
JG 6th and Kato GJ: Iron, inflammation, and early death in adults
with sickle cell disease. Circ Res. 116:298–306. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Samarron SL, Miller JW, Cheung AT, Chen
PC, Lin X, Zwerdling T, Wun T and Green R: Homocysteine is
associated with severity of microvasculopathy in sickle cell
disease patients. Br J Haematol. 190:450–457. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Erden-Inal M, Sunal E and Kanbak G:
Age-related changes in the glutathione redox system. Cell Biochem
Funct. 20:61–66. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
He T, Joyner MJ and Katusic ZS: Aging
decreases expression and activity of glutathione peroxidase-1 in
human endothelial progenitor cells. Microvasc Res. 78:447–452.
2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wald NJ, Watt HC, Law MR, Weir DG,
McPartlin J and Scott JM: Homocysteine and ischemic heart disease:
Results of a prospective study with implications regarding
prevention. Arch Intern Med. 158:862–867. 1998.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Bizheh N and Jaafari M: The effect of a
single bout circuit resistance exercise on homocysteine, hs-CRP and
fibrinogen in sedentary middle aged men. Iran J Basic Med Sci.
14:568–573. 2011.PubMed/NCBI
|
|
32
|
Vilas-Boas W, Veloso Cerqueira BA,
Figueiredo CV, Santiago RP, da Guarda CC, Pitanga TN, Santana SS,
Dias Zanette AM and Goncalves Mde S: Association of homocysteine
and inflammatory-related molecules in sickle cell anemia.
Hematology. 21:126–131. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kuo HK, Sorond FA, Chen JH, Hashmi A,
Milberg WP and Lipsitz LA: The role of homocysteine in multisystem
age-related problems: a systematic review. J Gerontol A Biol Sci
Med Sci. 60:1190–1201. 2005.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Bjørke Monsen AL and Ueland PM:
Homocysteine and methylmalonic acid in diagnosis and risk
assessment from infancy to adolescence. Am J Clin Nutr. 78:7–21.
2003.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Fan R, Zhang A and Zhong F: Association
between homocysteine levels and all-cause mortality: A
dose-response meta-analysis of prospective studies. Sci Rep.
7(4769)2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Schini-Kerth VB: Homocysteine, a
proinflammatory and proatherosclerotic factor: Role of
intracellular reactive oxygen species. Circ Res. 93:271–273.
2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Must A, Jacques PF, Rogers G, Rosenberg IH
and Selhub J: Serum total homocysteine concentrations in children
and adolescents: Results from the third national health and
nutrition examination survey (NHANES III). J Nutr. 133:2643–2649.
2003.PubMed/NCBI View Article : Google Scholar
|
